A new study was conducted to better understand the landscape of coverage of non-pharmacologic treatments for chronic pain among public and private insurers in the United States. Here’s what it found.
Drug costs are increasing, but so is patient cost sharing. That’s raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.